Bile acids (BAs) are considered to be promotive factors in colorectal carcinogenesis. We investigated whether BAs in the cellular environment influence proliferation of intestinal epithelial cell lines. Some BAs induced proliferation in several epithelial cell lines. In the proliferation assay, significant increases in IEC-6 cell proliferation were observed in response to glycodeoxycholic acid or glycochenodeoxycholic acid (GCDCA). Among the glycine-conjugated derivatives of BAs, especially GCDCA reduced cAMP production in IEC-6 cells. Pertussis toxin completely inhibited the GCDCA-induced increase in IEC-6 proliferation, suggesting GCDCA-induced proliferation required Gαi activation and cAMP reduction. Treatment with 3-isobutyl-1-methylxanthine, a phosphodiesterase inhibitor, also suppressed GCDCA-induced IEC-6 proliferation. We confirmed an increase in MEK1/2 phosphorylation in GCDCA-treated IEC-6 cells, and inhibition of MEK1/2 by U0126 clearly suppressed GCDCA-induced IEC-6 cell proliferation. A significant increase was observed in the phosphorylation of histone H2AX in GCDCA-treated IEC-6 cells after exposure to γ-rays. Cell cycle analysis revealed that GCDCA increased the proportion of cells in S phase only after γ-ray exposure. These results indicate that glycine-conjugated BAs in the cellular environment are potent inducers of cell proliferation accompanied by genomic instability in intestinal epithelia.
Bile acids (BAs) have been shown to promote colorectal carcinogenesis (1) . Several reports show that oral administration of BAs promoted colorectal carcinogenesis induced by chemical carcinogens in experimental animals (19) (20) (21) . In experimental carcinogenesis studies, researchers have measured the incidence of pre-neoplastic lesions and/or tumors induced by carcinogen treatments (2, 22) , reporting that cholic acid (CA), one of the primary BAs, increased the number of mucin-depleted foci in the large intestine of rats treated with a chemical carcinogen (5) . However, almost no data are available concerning BA metabolism, including taurine and glycine conjugates, in these experiments. We have established a reliable extraction and analytical method for BA profiles in biological samples using ultra performance liquid chromatography/mass spectrometry (8) . We found that CA ingestion increased the concentrations of taurine-and glycineconjugated BAs as well as unconjugated CA and deoxycholic acid (DCA) in serum and the luminal contents of the large intestine (9) . Gallstone patients are at high risk for proximal colon cancer (24) . These observations indicate that an inhibition of BA excretion results in an increase in serum concentrations of conjugated BAs and promotes the consequent risk for colorectal carcinogenesis. Genomic stability was retarded in DNA damaged cells even after the treatment ended (30) . Conjugated BAs might be involved in genomic instability as well as cell proliferation in intestinal epithelia. In this study, we investigated the influence of conjugated BAs on the proliferation and genomic cells/well on 48-well plates and incubated for 24-72 h. After washing twice with 1 mmol/L IBMX in DMEM without FBS, the cells were immersed in FBS-free DMEM for 20 min, followed by exposure to FBS-free medium containing each BA for 4 min. The intracellular cAMP concentration was measured using a cAMP EIA system (RPN2251, Biotrak; GE Healthcare UK Ltd., Buckinghamshire, UK).
RNA isolation and RT-PCR.
Total RNA was isolated from the cells exposed to each BA at the indicated concentrations for 96 h, using RNeasy mini kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. Complementary DNA was synthesized from total RNA using Reverscript I (Wako Pure Chemical Industries, Ltd., Osaka, Japan) with a random 9-mer primer (Toyobo Co., Ltd., Osaka, Japan). The cDNA was subjected to PCR using GoTaq master mix (Promega Co., Madison, WI, USA) and the following primer sets: TGR5 (NM_177936) forward: 5′-CCACTGCCCTTCTCTC TGTC-3′, reverse: 5′-GGTCTTCCTCGAAGCAC TTG-3′ (annealing temperature, 58.0°C; product size, 379 bp); and GAPDH (NM_017008) forward: 5′-TCCACCACCCTGTTGCTGTAG-3′, reverse: 5′-GACCACAGTCCATGACATCACT-3′ (annealing temp, 54°C; product size, 453 bp). Each product (10 μL) was separated by electrophoresis on a agarose gel. The gels were stained with ethidium bromide and visualized on a UV transilluminator.
Antibodies and Western blot analysis. Rabbit antiphospho-p44/p42 (p-ERK1/2), rabbit anti-p44/p42 (ERK1/2), rabbit anti-phospho-MEK (p-MEK), rabbit anti-phospho-cRAF (p-cRAF), and horseradish peroxidase (HRP)-conjugated anti-rabbit IgG antibodies were purchased from Cell Signaling Technology, Inc. Rabbit anti-phospho-histone H2AX (γ-H2AX) was obtained from Upstate Biotechnology (Temecula, CA, USA). Mouse anti-histone H2AX was purchased from R&D Systems, Inc. (Minneapolis, MN, USA). HRP-conjugated anti-mouse IgG antibody was purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Cells were lysed in a lysis buffer (25 mmol/L Tris-HCl, 150 mmol/L NaCl, 5 mg/mL sodium deoxycholate, 1 mg/mL SDS, 1 mmol/L EDTA tetrasodium salt, 1 mmol/L EGTA disodium salt, pH 7.5) containing NP-40, protease inhibitors (5 ng/mL aprotinin, 5 mmol/L benzamidine, 3 ng/mL leupeptin, 1 mmol/L phenylmethane sulfonyl fluoride), and phosphatase inhibitors (2 mmol/L sodium orthovanadate, 10 mmol/L sodium fluoride, 50 mmol/L glycerstability of intestinal epithelial cell lines after exposure to γ-rays.
MATERIALS AND METHODS
Chemicals. Sodium cholate (CA, 5β-cholanic acid-3α,7α,12α-triol), sodium deoxycholate (DCA, 5β-cholanic acid-3α,12α-diol), sodium chenodeoxycholate (CDCA, 5β-cholanic acid-3α,7α-diol), sodium taurocholate (TCA, 5β-cholanic acid-3α,7α,12α-triol-N-(2-sulphoethyl)-amide), sodium taurodeoxycholate (TDCA, 5β-cholanic acid-3α,12α-diol-N-(2-sulphoethyl)-amide), sodium taurochenodeoxycholate (TCDCA, 5β-cholanic acid-3α,7α-diol-N-(2-sulphoethyl)-amide), sodium glycocholate, (GCA, 5β-cholanic acid-3α,7α,12α-triol-N-(carboxymethyl)-amide), sodium glycodeoxycholate (GDCA, 5β-cholanic acid-3α,12α-diol-N-(carboxymethyl)-amide), and sodium glycochenodeoxycholate (GCDCA, 5β-cholanic acid-3α,7α-diol-N-(carboxymethyl)-amide), pertussis toxin (Ptx), and 3-isobutyl-1-methylxanthine (IBMX) were purchased from Sigma-Aldrich Co. Cell culture. The IEC-6 cell line was obtained (ATCC CRL 1592) from American Type Culture Collection (Manassas, VA, USA) at passage 11. The cell line is derived from normal rat intestine (26) . Mycoplasma was not detected in the cultures. The cells were maintained in Dulbecco's Modified Eagle's Medium (DMEM, 12100-046; Gibco ® , Invitrogen Co., Carlsbad, CA, USA) supplemented with 5% heat-inactivated FBS, 0.1 U/mL insulin, 35 μg/mL penicillin G potassium, and 100 μg/mL streptomycin sulfate and were incubated at 37°C in a humidified atmosphere 95% air and 5% CO 2 .
Cell proliferation assay. Cells were seeded at 1.5 × 10 3 cells/well on 96-well plates and incubated in DMEM for 24 h. Then, cells were exposed to DMEM containing each BA for 72 h. The cell number was measured using a cell counting kit-8 (Dojindo, Kumamoto, Japan) according to the manufacturer's guidelines. The optical density of the culture supernatant was determined at 450 nm for measurement and at 655 nm for reference.
Determination of intracellular cAMP concentration.
Cells were plated at a density of 6 × 10 4 to 10 × 10 in a dose-dependent manner. CDCA, another unconjugated BA, at concentrations up to 100 μM promoted IEC-6 cell proliferation, but at the concentrations beyond 200 μM CDCA inhibited the proliferation. All the taurine-conjugated BAs (TCA, TDCA, and TCDCA) and some glycine-conjugated BAs (GDCA and GCDCA) promoted proliferation in IEC-6 cells at a higher concentration. No significant influence of GCA was found in this range of the concentrations. Next, we investigated the intracellular signaling in IEC-6 proliferation induced by the addition of conjugated BAs (Fig. 2) . One early intracellular signaling event is cAMP production (11, 29) . BA activates a G protein-coupled receptor (GPCR), TGR5 (13) . In our study, there was a prominent reduction of cAMP in IEC-6 cells after exposure to the glycine-conjugated BAs (GDCA and GCDCA) ( Fig. 2A) . GCA also reduced the cAMP concentration in IEC-6 cells (Fig. 2B ). Compared with GCA and GDCA, GCDCA suppressed the cAMP concentration to a greater extent.
We examined the involvement of phosphodiesterase (PDE), which degrade phosphodiester bond in ol 2-phosphate disodium salt). Proteins (20 μg) from whole-cell lysates were separated by SDS-PAGE in 10% gels and detected immunologically following electrotransfer onto Immun-Blot PVDF membranes (Bio-Rad). Proteins and molecular weight markers were visualized by Ponceau S staining. After a blocking step, the membranes were probed with the indicated antibodies in 20 mmol/L Tris-HCl containing 2.5% powdered milk and 0.05% Tween-20 (pH 7.6), at 4°C for 12 h with gently shaking. The membranes were subsequently incubated with HRPconjugated secondary antibody at room temperature for 1 h, and the immunocomplexes were visualized using an ECL Plus detection system (GE Healthcare). Quantitative analysis of the Western blots were performed using a Lumivision Pro 400EX system (Aisin Seiki, Co., Ltd., Kariya, Japan).
Irradiation and cell cycle analysis. Cells (1 × 10 6 ) were seeded on a T-25 flask and incubated in DMEM with or without 200 μmol/L GCDCA until almost confluent. The cells were then exposed to 2 Gy of γ-rays using a 60 Co-γ-irradiator (Cobalt-60 Teletherapy Apparatus RCR-120-C3; Toshiba, Kanagawa, Japan) at room temperature. The dose rate of γ-rays from the 60 Co source was 0.26 Gy/min. On postirradiation day 2, the cells were cultured for an additional 23 days, then harvested for cell cycle analysis and H2AX analysis on Western blots. For cell cycle analysis, the recovered cells were fixed with ethanol and stained with propidium iodide. The proportion of cells in S phase was determined using a FACSCalibur (Becton, Dickson and Company, Franklin Lakes, NJ, USA). The data were quantitatively analyzed using FlowJo software (Treestar Inc., Ashland, OR, USA).
Statistical analysis. The software package JMP 5.0 (SAS Institute Inc., Cary, NC, USA) was used for all statistical analyses. All results are expressed as the mean ± SEM. Comparisons between two groups and among multiple groups were evaluated using a Student's t-test and Tukey-Kramer's test, respectively. A probability of less than 0.05 was considered statistically significant.
RESULTS
We first investigated whether conjugated BAs influence IEC-6 cells, a model of undifferentiated epithelial cells originating from intestinal epithelia (26) . The proliferation of IEC-6 cells was inhibited by the addition of some unconjugated CA or DCA (Fig. 1)   Fig. 1 Influence of BAs on IEC-6 cell proliferation. IEC-6 cells were cultured with or without supplementation of various BAs at the indicated concentrations for 72 h, and cell proliferation was measured. BAs used in this experiment were unconjugates (CA, DCA, CDCA), taurine-conjugates (TCA, TDCA, TCDCA) and glycine-conjugates (GCA, GDCA, GCDCA). Values shown are means ± SEMs (n = 5). Values with different superscript letters are significantly different in each treatment (P < 0.05).
the culture medium did not inhibit CDCA-induced IEC-6 proliferation (Fig. 3) , indicating that FXR is not involved in BA-induced IEC-6 proliferation. The RAS/RAF/MEK/ERK signaling pathway is well known as a proliferation-related signal cascade (4). We determined the involvement of the MEK-ERK pathway in IEC-6 proliferation induced by GCDCA (Fig. 4) . GCDCA clearly increased ERK phosphorylation (Fig. 4A) . Inhibition of MEK, the upstream signal, by U0126 completely suppressed GCDCA-induced IEC-6 proliferation (Fig. 4B) . The phosphorylation of MEK was also induced by GCD-CA supplementation and was completely inhibited by co-administration of Ptx (Fig. 4C) , suggesting that G proteins are involved in the up-regulation of MEK phosphorylation by GCDCA. In contrast, neither GCDCA supplementation nor Ptx influenced c-RAF phosphorylation (Fig. 4D) , an upstream signal in the MEK pathway (27, 28) . Thus, GCDCA promoted IEC-6 cell proliferation via G-proteins, cAMP reduction, and the MEK-ERK pathway. Then, we determined whether GCDCA influences genomic stability in IEC-6 cells (Fig. 5) . The histone γ-H2AX is found at the sites of DNA strand breaks in the nucleus, where it recruits factors associated with DNA repair (6) . In the present study, GCDCA-treated IEC-6 cells were exposed to 2 Gy of γ-rays and further cultured for 3 weeks. The amount of γ-H2AX, determined by Western blot analysis (Fig. 5A, Fig. 5B ), increased in response to GCDCA in the cells exposed to γ-rays, and GCDCA treatment strongly increased the proportion of the second messengers such as cAMP and cGMP, in GCDCA-induced IEC-6 cell proliferation. The treatment with IBMX, a PDE inhibitor (17) , abolished GCDCA-induced IEC-6 proliferation (Fig. 2C) . A reduction of cAMP production appeared to be required for GCDCA-induced cell proliferation. Furthermore, Ptx, a G protein inhibitor, completely suppressed GCDCA-induced IEC-6 proliferation (Fig. 2D) . Thus, a G protein and the reduction of cAMP were required for GCDCA-induced IEC-6 cell proliferation. We confirmed expression of TGR5 in IEC-6 cells (data not shown). Another possible receptor for BA is the farnesoid X receptor (FXR) (18) . We tried to find the cell proliferation using a FXR inhibitor, gugglesterone, and CDCA as a BA, owing to its agonist activity for FXR and its ability to induce IEC-6 cell proliferation. The addition of gugglesterone to cells in S phase after exposure to γ-rays, although BA treatment did not affect that in non-irradiated cells (Fig. 5C) , suggesting that the check point system in cell cycle was retarded in the irradiated IEC-6 cells cultured with GCDCA.
DISCUSSION
It is generally accepted that BAs induce cell death of intestinal epithelial cells (25) . However, this study demonstrated that a variety of BAs, especially the taurine-conjugates (TCA, TDCA, and TCDCA) and glycine conjugates (GDCA and GCDCA) promoted the proliferation of IEC-6 cells. Among these BAs, GCDCA promoted IEC-6 cell proliferation via intracellular signaling involving Gαi activation, reduction of cAMP levels, and the MAPK pathway (Fig. 6) . In contrast, all the taurine-conjugated BAs did not decrease cAMP concentration (Fig. 2A) , indicates that mode of the promotion is different between the taurine-and glycine-conjugates. GDCA activates Gαi in hepatocytes (3) and promotes cell proliferation of Barrett's adenocarcinoma cells via the phosphatidylinositol-3-kinase pathway (10) . Therefore, glycine-conjugated BAs may activate a signaling pathway in IEC-6 cells, leading to cell proliferation. FXR is one candidate for BA recognition (18), but our study did not support the involvement of FXR in CDCA-induced IEC-6 cell proliferation. The present study indicates that GPCRs are responsible for CDCA-induced IEC-6 cell proliferation, and we confirmed the expression of TGR5 in IEC-6 cells. TGR5 mainly recognizes secondary bile acids such as DCA and lithocholic acid including their taurine and glycine conjugates in TGR5-transfected CHO cells with a promotion of cAMP concentration (13) . In the present study, we did not observe any increase in cAMP in IEC-6 cells under cretion from STC-1 cells through TGR5 (12) . STC-1 cells, which originate from enteroendocrine cells, are widely used as a model of intestinal L-cells. GLP-2, another hormone secreted from L-cells, contributes to epithelial cell proliferation and colorectal cancer development (31) . As the present study was performed in cultured cells, we can exclude the involvement of gastrointestinal hormones in GCDCAinduced IEC-6 cell proliferation. However, the enteroendocrine system may be associated with BAinduced epithelial cell proliferation in vivo.
In our previous study, we found that the oral administration of CA induced prominent increases in the concentrations of taurine-and glycine-conjugated BAs in both the luminal contents and the serum (9) , indicating that the influence of BAs on epithelial cells occurs not only on the luminal side but also on the serosal side. The phosphorylation of histone H2AX has been reported in cells after exposure to DNA-damaging treatments (6) . It was suggested that γ-H2AX accumulated at the site of DNA strand breaks even long after exposure, indicating that this is a marker for genomic instability (30) . We demonstrated that GCDCA treatment increased the concentration of γ-H2AX in IEC-6 cells after exposure to γ-rays. GCDCA has been shown to induce oxidative DNA damage in cholangiocytes (16) . Our results suggest that the presence of GCDCA in the cellular environment reduced genomic stability in DNA-damaged IEC-6 cells as well as promoted cell proliferation. GDCA also increased γ-H2AX in IEC-6 cells in response to γ-rays (data not shown). Gallstone patients are at high risk for proximal colon cancer (24) . It is considered that gallstones partially inhibit bile efflux and BA excretion from the bile duct, resulting in an elevated serum BA concentration. Thus, glycineconjugated BAs may be responsible for the increased risk for colon carcinogenesis in gallstone patients, owing to their promotion of intestinal epithelial proliferation and genomic instability. The elucidation of the precise roles of BAs in the disruption of genomic stability in intestinal epithelial cells will be of interest in further studies.
In conclusion, some glycine-and taurine-conjugated BAs promoted IEC-6 cell proliferation in a concentration-dependent manner. The signaling pathways in conjugated BA-induced IEC-6 proliferation depended on the conjugated molecules. Gαi activation and cAMP reduction are responsible for the promotion of IEC-6 cell proliferation by glycineconjugated BAs.
BA stimulations. Moreover, all the glycine-conjugated BAs (GCA, GDCA, GCDCA) reduced the cAMP concentrations ( Fig. 2A and 2B ). At least, the mode of action in cell proliferation in IEC-6 appears to be different between taurine-and glycine-conjugated BAs. Several reports have shown that BAs increase cAMP production via TGR5 (14, 15) , and an increase in cAMP production suppresses cell proliferation via the inhibition of ERK1/2 phosphorylation (7). On the contrary, we found that the inhibition of PDE by IBMX blocked ERK1/2 phosphorylation and the GCDCA-induced cell proliferation in IEC-6 cells. Thus, GPCRs other than TGR5 may be responsible for the GCDCA-induced reduction of cAMP and the promotion of cell proliferation. In the present study, we showed that GCDCA induced ERK1/2 phosphorylation via MAPK activation. However, the phosphorylation of c-RAF, an upstream signal for MAPK, was not involved in GCDCA-induced proliferation. G proteins appear to be key components in GCDCA-induced IEC-6 cell proliferation, as Ptx successfully inhibited GCDCA-induced IEC-6 cell proliferation. It was reported that βγ subunits of Gi/o enhance ERK1/2 phosphorylation in PC12 cells (23) . This pathway may also be involved in GCDCAinduced IEC-6 cell proliferation. BAs promote glucagon-like peptide (GLP)-1 se- Fig. 6 Putative signal transduction in IEC-6 cell proliferation and subsequent genomic instability induced by glycochenodeoxycholic acid (GCDCA). AC, adenylyl cyclase; cAMP, cyclic AMP; GPCR, G protein-coupled receptor; IBMX, 3-isobutyl-1-methylxanthin; PDE, phosphodiesterase; Ptx, pertussis toxin.
